BR9711296A - Composto processo terap-utico para inibir o crescimento de c-lulas de c ncer e composi-Æo farmac-utica - Google Patents

Composto processo terap-utico para inibir o crescimento de c-lulas de c ncer e composi-Æo farmac-utica

Info

Publication number
BR9711296A
BR9711296A BR9711296A BR9711296A BR9711296A BR 9711296 A BR9711296 A BR 9711296A BR 9711296 A BR9711296 A BR 9711296A BR 9711296 A BR9711296 A BR 9711296A BR 9711296 A BR9711296 A BR 9711296A
Authority
BR
Brazil
Prior art keywords
inhibit
growth
pharmaceutical composition
cancer cells
therapeutic process
Prior art date
Application number
BR9711296A
Other languages
English (en)
Inventor
Edmond J Lavoie
Leroy Fong Liu
Darshan B Makhey
Original Assignee
Univ Rutgers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rutgers filed Critical Univ Rutgers
Publication of BR9711296A publication Critical patent/BR9711296A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BR9711296A 1996-09-23 1997-09-23 Composto processo terap-utico para inibir o crescimento de c-lulas de c ncer e composi-Æo farmac-utica BR9711296A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2651196P 1996-09-23 1996-09-23
PCT/US1997/017012 WO1998012181A1 (en) 1996-09-23 1997-09-23 Substituted heterocycles as anti-tumor agents

Publications (1)

Publication Number Publication Date
BR9711296A true BR9711296A (pt) 1999-08-17

Family

ID=21832257

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9711296A BR9711296A (pt) 1996-09-23 1997-09-23 Composto processo terap-utico para inibir o crescimento de c-lulas de c ncer e composi-Æo farmac-utica

Country Status (14)

Country Link
US (1) US5981541A (pt)
EP (1) EP0950054A1 (pt)
JP (1) JP2001501197A (pt)
KR (1) KR20000048537A (pt)
AU (1) AU725938B2 (pt)
BR (1) BR9711296A (pt)
CA (1) CA2266321A1 (pt)
CZ (1) CZ102499A3 (pt)
IL (1) IL129096A0 (pt)
NO (1) NO991384L (pt)
NZ (1) NZ334954A (pt)
PL (1) PL332416A1 (pt)
TR (1) TR199900636T2 (pt)
WO (1) WO1998012181A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL137351A0 (en) 1998-02-12 2001-07-24 Univ Rutgers Heterocyclic topoisomerase poisons
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US8133421B2 (en) * 1999-02-23 2012-03-13 Warsaw Orthopedic, Inc. Methods of making shaped load-bearing osteoimplant
US20070233272A1 (en) * 1999-02-23 2007-10-04 Boyce Todd M Shaped load-bearing osteoimplant and methods of making same
US6740650B2 (en) 1999-10-29 2004-05-25 Rutgers, The State University Of New Jersey Heterocyclic cytotoxic agents
US20030139409A1 (en) 1999-12-02 2003-07-24 John Milton Benzo[A] [phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and II
GB9928542D0 (en) * 1999-12-02 2000-02-02 Xenova Ltd Pharmaceutical compounds
DE60130748T2 (de) * 2000-03-27 2008-07-17 N.V. Organon Nicht-steroidale tetracyclische verbindungen für östrogen-verwandte behandlungen
KR100381716B1 (ko) * 2000-10-09 2003-04-26 한국화학연구원 항암활성을 가지는 아크리딘 유도체
MXPA04004607A (es) 2001-11-14 2004-09-10 Univ Rutgers Agentes de venenos de topoisomerasa solubilizados.
AU2002352708A1 (en) 2001-11-14 2003-05-26 Edmond J. Lavoie Cytotoxic agents
KR20050044491A (ko) 2001-11-14 2005-05-12 루트거스, 더 스테이트 유니버시티 가용화된 토포이소머라제 독
WO2003047505A2 (en) 2001-11-14 2003-06-12 Rutgers, The State University Topoisomerase poison agents
US6992089B2 (en) * 2002-08-09 2006-01-31 Rutgers, The University Of New Jersey Nitro and amino substituted topoisomerase agents
WO2004014918A1 (en) * 2002-08-09 2004-02-19 Rutgers, The State University Nitro and amino substituted topoisomerase agents
AU2003265405A1 (en) * 2002-08-09 2004-02-25 Edmond J. Lavoie Nitro and amino substituted heterocycles as topoisomerase i targeting agents
WO2004044174A2 (en) 2002-11-12 2004-05-27 Rutgers, The State University Topoisomerase-targeting agents
EP2403856B1 (en) 2009-03-06 2012-12-19 Rutgers, The State University of New Jersey Methylenedioxybenzo [i]phenanthridine derivatives used to treat cancer
WO2010127363A1 (en) 2009-05-01 2010-11-04 Rutgers, The State University Of New Jersey Toposiomerase inhibitors
CN102918044A (zh) * 2010-05-21 2013-02-06 深圳信立泰药业股份有限公司 一种稠环喹唑啉类衍生物及其应用
CN102351870B (zh) * 2011-08-25 2014-03-12 中山大学 一种苯并吖啶衍生物的制备方法及其作为抗癌药物的用途
CN105669551B (zh) * 2015-12-02 2018-04-17 广西中医药大学 7‑苯并(c)吖啶对氟苯甲酰胺基硫脲及其制备方法和用途
US11091498B2 (en) 2016-04-04 2021-08-17 Rutgers, The State University Of New Jersey Topoisomerase poisons

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US26065A (en) * 1859-11-08 Improvement in cotton-gins
US2981731A (en) * 1961-04-25 Acridine derivatives
USRE26065E (en) 1966-07-19 Folybenzimidazoles and their preparation
US2985661A (en) * 1956-02-06 1961-05-23 American Cyanamid Co Preparation of 2(omicron-aminophenyl)-benzimidazole
US2915523A (en) * 1956-12-03 1959-12-01 Parke Davis & Co Benzacridine compounds
US3272707A (en) * 1964-07-17 1966-09-13 Smith Kline French Lab Pharmaceutical compositions and methods for their use
CH420045A (de) * 1964-09-01 1967-03-15 Ciba Geigy Verwendung von neuen Poly-azolen als optische Aufhellmittel für textile organische Materialien
US3267107A (en) * 1964-09-17 1966-08-16 American Home Prod 3-(4'-5'-methylenedioxy-phenyl)-7, 8-dimethoxy-1, 2, 3, 4,-tetrahydroisoquinolines
US3849561A (en) * 1964-10-20 1974-11-19 S Naruto Anti-peptic ulcer substance from corydalis tubers
DE1670684A1 (de) * 1966-04-01 1970-12-03 Hoechst Ag Verfahren zur Herstellung von basisch substituierten Bis-benzimidazol-derivaten
JPS4942700A (pt) * 1972-08-25 1974-04-22
US4980344A (en) * 1982-05-14 1990-12-25 Maroko Peter R Compositions for improving circulatory performance
JPS61130289A (ja) * 1984-11-29 1986-06-18 Ss Pharmaceut Co Ltd １３−プロピルベルベリンの塩
US5244903A (en) * 1987-03-31 1993-09-14 Research Triangle Institute Camptothecin analogs as potent inhibitors of topoisomerase I
JP2700475B2 (ja) * 1988-07-30 1998-01-21 コニカ株式会社 非線形光学材料および非線形光学素子
US4938949A (en) * 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US5106863A (en) * 1990-03-26 1992-04-21 Ortho Pharmaceutical Corporation Substituted imidazole and pyridine derivatives
US5135934A (en) * 1990-07-06 1992-08-04 Du Pont Merck Pharmaceutical Company 3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents
US5126351A (en) * 1991-01-24 1992-06-30 Glaxo Inc. Antitumor compounds
US5223506A (en) * 1991-06-04 1993-06-29 Glaxo Inc. Cyclic antitumor compounds
US5428040A (en) * 1993-08-31 1995-06-27 The Du Pont Merck Pharmaceutical Company Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
WO1995009153A1 (en) * 1993-09-28 1995-04-06 Kyowa Hakko Kogyo Co., Ltd. Novel tetracyclic compound

Also Published As

Publication number Publication date
JP2001501197A (ja) 2001-01-30
EP0950054A1 (en) 1999-10-20
AU725938B2 (en) 2000-10-26
US5981541A (en) 1999-11-09
PL332416A1 (en) 1999-09-13
CA2266321A1 (en) 1998-03-26
CZ102499A3 (cs) 1999-09-15
KR20000048537A (ko) 2000-07-25
NO991384D0 (no) 1999-03-22
WO1998012181A1 (en) 1998-03-26
IL129096A0 (en) 2000-02-17
NZ334954A (en) 2000-08-25
AU4589797A (en) 1998-04-14
TR199900636T2 (xx) 1999-10-21
NO991384L (no) 1999-05-20

Similar Documents

Publication Publication Date Title
BR9707425A (pt) Composto processo terapêutico para inibir o crescimento de células cancerosas e processo para utilizar o composto
BR9608638A (pt) Processo e composição farmacêutica para o tratamento seletivo do crescimento e diferenciação de células e composto
BR9612204A (pt) Composto uso do composto composição farmacêutica e processo para preparação do composto e para o tratamento de dor
EE04390B1 (et) Paikne preparaat dermatoloogiliste seisundite raviks
DE69734499D1 (de) Sonnenschutzmittel aus langkettigen, verzweigten Alkylbenzoaten oder Alkylhydroxybenzoaten
BR9602933A (pt) Compostos processos para preparação de composto e de composição farmacêutica e composto
BR9604950A (pt) Composição farmacêutica contendo n-clorofenil carbamatos n-clorofeniltiocarbamatos e derivados de n-fosfonoglicina para inibir o crescimento de cânceres e vírus em mamíferos
BR8603566A (pt) Composicao para o tratamento de tecidos
ATE246490T1 (de) Pharmazeutische zusammensetzung von topiramate
BR9611198A (pt) Composto processo de preparação do mesmo e composição farmacêutica
WO1993021942A3 (en) Use of mmp inhibitors
BR9408148A (pt) Processo para tratamento de arritmia composto e formulação farmacêutica
FI970918L (fi) Yhdisteet ja menetelmät syövän hoitamiseksi
BR9609920A (pt) Uso de griseofulvina para inibir o crescimento de cânceres
BR9600340A (pt) Composto composição e processo para estabilizar um material orgânico
BR9607346A (pt) Composto utilizaç o de um composto composiç o farmacéutica e processo para o tratamento de um mamifero e para e preparaç o de compostos
BR8502985A (pt) Composicao e processo para o tratamento de solo
PT917464E (pt) Aminas para o fabrico de medicamentos uteis para impedir a proliferacao de celulas tumorais
BR9608476A (pt) Composto processo para inibir o crescimento de uma célula tumoral de mam¡fero e composicão terapéutica
PT897667E (pt) Composicao para melhorar o pao
ITRM970731A1 (it) Composizione per il trattamento di ustioni eritemi solari abrasioni piaghe e irritazioni cutanee
BR9302389A (pt) Composto,formulacao farmaceutica e processo para preparar o composto
ITMI922492A0 (it) Composizione e procedimento per la preparazione di vetri organici
ID17875A (id) Komposisi farmasi yang mengandung asam 4-oksobutanoat
BR8502987A (pt) Composicao e processo para o tratamento de solo

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.